Last reviewed · How we verify
LMWH and Phenprocoumon — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
LMWH and Phenprocoumon (LMWH and Phenprocoumon) — Bayer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LMWH and Phenprocoumon TARGET | LMWH and Phenprocoumon | Bayer | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LMWH and Phenprocoumon CI watch — RSS
- LMWH and Phenprocoumon CI watch — Atom
- LMWH and Phenprocoumon CI watch — JSON
- LMWH and Phenprocoumon alone — RSS
Cite this brief
Drug Landscape (2026). LMWH and Phenprocoumon — Competitive Intelligence Brief. https://druglandscape.com/ci/lmwh-and-phenprocoumon. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab